Overview

Dasotraline SEP360-105 Pediatric PK/PD Study

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Pediatric PK study of SEP-225289 (Dasotraline)
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion